Investor Information
Malarex is a new
anti-parasite treatment in a
$10 billion market where the World Health Organization has made new anti-malarial treatments a priority.
CORPORATION
FACT SHEET
FINANCIALS-SEC
CORPORATE
COMMUNIQUÉ
INFORMATION REQUEST
INVESTOR RELATION
CONTACTS

FINANCIALS-SEC


Click here for our SEC Filings

Click here for Quotes and information (Yahoo FInance)


Click here for our Proxy Filings

Click here for our Quarterly Filings

Click here for our Year End 2007 Filings